GlassScriptPhysician profile
Yeshvant Navalgund
NPI 1558354738
$387,507.29
in general payments reported to CMS, 2019-2025
46 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91K · 2020: $29K · 2021: $46K · 2022: $109K · 2023: $65K · 2024: $36K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $51K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Travel and Lodging: $17K · Food and Beverage: $9,026 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,500 · Consulting Fee: $2,816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $50,857.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,831.25 |
| Travel and Lodging | $17,452.00 |
| Food and Beverage | $9,025.74 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,500.00 |
| Consulting Fee | $2,816.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $106,478.57 | 2019-2025 | Proclaim, Eterna, Durata |
| Averitas Pharma INC. | $72,073.90 | 2023-2024 | Qutenza |
| Grt US Holding, INC. | $65,518.27 | 2021-2022 | |
| Si-Bone, INC. | $42,134.64 | 2019-2023 | |
| Medtronic USA, INC. | $42,122.66 | 2019-2020 | |
| Medtronic, INC. | $24,598.36 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Tersera Therapeutics LLC | $11,381.16 | 2021-2023 | Prialt |
| Nevro Corp. | $10,108.41 | 2019-2024 | Senza |
| Zimmer Biomet Holdings, INC. | $4,265.67 | 2019-2020 | |
| Mml US, INC. | $1,995.74 | 2021-2025 | Reactiv8 |
| Biotronik Nro, INC. | $1,005.33 | 2023-2025 | Prospera, Biotronik |
| Boston Scientific Corporation | $976.87 | 2021-2025 | Infinion 16, Wavewriter Alpha Prime 16, Intracept |
| Spinefrontier, INC. | $812.20 | 2025 | Facetfuse, Nanofuse, Sijfuse |
| Vertos Medical, INC. | $801.51 | 2022-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $397.25 | 2024-2025 | Evoke |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $253.00 | 2021 | |
| Almatica Pharma LLC | $247.95 | 2021-2023 | Gralise |
| Curonix LLC | $226.56 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Integra Lifesciences Corporation | $205.33 | 2021 | |
| Stimwave Technologies Incorporated | $183.50 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $147.74 | 2022-2024 | Ajovy |
| Relievant Medsystems, INC. | $138.68 | 2021 | |
| Abbvie INC. | $135.64 | 2022-2023 | |
| Spinal Simplicity, LLC | $127.22 | 2022-2025 | Ha Minuteman G3-R |
| Stratus Medical, LLC | $126.37 | 2023 | Nimbus |
| Protega Pharmaceutials INC | $124.50 | 2023 | Roxybond |
| Collegium Pharmaceutical, INC. | $105.19 | 2022-2024 | Xtampza |
| Pfizer INC. | $103.49 | 2021-2024 | |
| Convatec INC. | $99.22 | 2025 | |
| Novocure INC. | $89.07 | 2020 | |
| Amgen INC. | $89.05 | 2022 | |
| Revance Therapeutics, INC. | $56.40 | 2024 | Daxi |
| Electronic Waveform Lab, INC. | $45.59 | 2022-2023 | |
| Ibsa Pharma INC. | $44.45 | 2023-2024 | Tirosint, Licart, Tirosint |
| Biodelivery Sciences International, INC. | $42.65 | 2021 | |
| Nalu Medical, INC. | $35.30 | 2023 | Nalu Neurostimulation System |
| Redhill Biopharma INC. | $32.28 | 2021-2022 | |
| Fidia Pharma USA INC. | $25.16 | 2024 | Triluron, Hymovis, Hyalgan |
| Ferring Pharmaceuticals INC. | $24.77 | 2022 | |
| Allergan, INC. | $22.24 | 2020 | |
| Foundation Fusion Solutions, LLC | $21.01 | 2022 | |
| Azurity Pharmaceuticals, INC. | $19.75 | 2023 | Horizant |
| Painteq LLC | $19.52 | 2024 | Painteq |
| Currax Pharmaceuticals LLC | $15.36 | 2022 | |
| Vertiflex, INC. | $15.33 | 2019 | |
| Amneal Pharmaceuticals LLC | $14.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yeshvant Navalgund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.